Sedative medicines have been used for anxiety, sleep and other conditions for decades. As experience developed, dependence and withdrawal became recognised alongside therapeutic benefits. Older classifications separated abuse and dependence; current discussions also distinguish physical adaptation during prescribed use from a pattern of impaired control and harm.
NICE NG215 and the MHRA's January 2026 communication give UK context for planned, collaborative withdrawal. A safe approach does not assume that either indefinite prescribing or abrupt discontinuation is appropriate for everyone.